Ethyl pyruvate protects against lipopolysaccharide-induced white matter injury in the developing rat brain

International Journal of Developmental Neuroscience

Volumn 31, Issue 3, 2013, Pages 181-188

  Wang, Yingyan ^a   Yin, Ping ^a   Huang, Shanying ^a   Wang, Jiwen ^a   Sun, Ruopeng ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Caspase 3; Ethyl pyruvate; Inflammation; Lipopolysaccharide; Oligodendrocyte; White matter injury

Indexed keywords

CASPASE 3; ETHYLPYRUVATE; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; PYRUVIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN DEVELOPMENT; BRAIN TISSUE; BRAIN VENTRICLE DILATATION; CELL LOSS; CONTROLLED STUDY; DRUG EFFECT; ENCEPHALITIS; MICROGLIA; MYELIN DEFICIENCY; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; PERINATAL PERIOD; PERIVENTRICULAR WHITE MATTER; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; STEREOTACTIC PROCEDURE; WHITE MATTER; WHITE MATTER INJURY;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CASPASE 3; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; NERVE FIBERS, MYELINATED; OLIGODENDROGLIA; PYRUVATES; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84873811931     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.12.005     Document Type: Article

References (51)

1. Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J., Kinney H.C. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2001, 21:1302-1312.
2. Back S.A. Perinatal white matter injury: the changing spectrum of pathology and emerging insights into pathogenetic mechanisms. Mental Retardation and Developmental Disabilities Research Reviews 2006, 12:129-140.
3. Back S.A., Riddle A., McClure M.M. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke: A Journal of Cerebral Circulation 2007, 38:724-730.
4. Billiards S.S., Haynes R.L., Folkerth R.D., Borenstein N.S., Trachtenberg F.L., Rowitch D.H., Ligon K.L., Volpe J.J., Kinney H.C. Myelin abnormalities without oligodendrocyte loss in periventricular leukomalacia. Brain Pathology 2008, 18:153-163.
5. Block M.L., Zecca L., Hong J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007, 8:57-69.
6. Cai B., Brunner M., Wang H., Wang P., Deitch E.A., Ulloa L. Ethyl pyruvate improves survival in awake hemorrhage. Journal of Molecular Medicine (Berlin) 2009, 87:423-433.
7. Cai Z., Pang Y., Lin S., Rhodes P.G. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Research 2003, 975:37-47.
8. Cai Z., Lin S., Pang Y., Rhodes P.G. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatric Research 2004, 56:377-384.
9. Cai Z., Lin S., Fan L.W., Pang Y., Rhodes P.G. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 2006, 137:425-435.
10. Cho I.H., Kim S.W., Kim J.B., Kim T.K., Lee K.W., Han P.L., Lee J.K. Ethyl pyruvate attenuates kainic acid-induced neuronal cell death in the mouse hippocampus. Journal of Neuroscience Research 2006, 84:1505-1511.
11. Choi J.S., Lee M.S., Jeong J.W. Ethyl pyruvate has a neuroprotective effect through activation of extracellular signal-regulated kinase in Parkinson's disease model. Biochemical and Biophysical Research Communications 2010, 394:854-858.
12. Dammann O., Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Current Opinion in Pediatrics 2000, 12:99-104.
13. Deng W., Pleasure J., Pleasure D. Progress in periventricular leukomalacia. Archives of Neurology 2008, 65:1291-1295.
14. Fan L.W., Pang Y., Lin S., Rhodes P.G., Cai Z. Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain. Neuroscience 2005, 133:159-168.
15. Fan L.W., Mitchell H.J., Tien L.T., Zheng B., Pang Y., Rhodes P.G., Cai Z. alpha-Phenyl-n-tert-butyl-nitrone reduces lipopolysaccharide-induced white matter injury in the neonatal rat brain. Developmental Neurobiology 2008, 68:365-378.
16. Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends in Immunology 2007, 28:138-145.
17. Folkerth R.D. Periventricular leukomalacia: overview and recent findings. Pediatric and Developmental Pathology: The Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2006, 9:3-13.
18. Genovese T., Esposito E., Mazzon E., Di Paola R., Meli R., Caminiti R., Bramanti P., Fink M.P., Cuzzocrea S. Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injury. Shock 2009, 32:217-227.
19. Girard S., Kadhim H., Larouche A., Roy M., Gobeil F., Sebire G. Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008, 43:54-62.
20. Han B.H., Xu D., Choi J., Han Y., Xanthoudakis S., Roy S., Tam J., Vaillancourt J., Colucci J., Siman R., Giroux A., Robertson G.S., Zamboni R., Nicholson D.W., Holtzman D.M. Selective, reversible caspase-3 inhibitor is neuroprotective and reveals distinct pathways of cell death after neonatal hypoxic-ischemic brain injury. The Journal of Biological Chemistry 2002, 277:30128-30136.
21. Han Y., Englert J.A., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate inhibits nuclear factor-kappaB-dependent signaling by directly targeting p65. The Journal of Pharmacology and Experimental Therapeutics 2005, 312:1097-1105.
22. Kadhim H., Khalifa M., Deltenre P., Casimir G., Sebire G. Molecular mechanisms of cell death in periventricular leukomalacia. Neurology 2006, 67:293-299.
23. Kalariya N.M., Reddy A.B., Ansari N.H., VanKuijk F.J., Ramana K.V. Preventive effects of ethyl pyruvate on endotoxin-induced uveitis in rats. Investigative Ophthalmology & Visual Science 2011, 52:5144-5152.
24. Kao K.K., Fink M.P. The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochemical Pharmacology 2010, 80:151-159.
25. Kaur C., Ling E.A. Periventricular white matter damage in the hypoxic neonatal brain: role of microglial cells. Progress in Neurobiology 2009, 87:264-280.
26. Khwaja O., Volpe J.J. Pathogenesis of cerebral white matter injury of prematurity. Archives of Disease in Childhood. Fetal and Neonatal Edition 2008, 93:F153-F161.
27. Kim H.S., Cho I.H., Kim J.E., Shin Y.J., Jeon J.H., Kim Y., Yang Y.M., Lee K.H., Lee J.W., Lee W.J., Ye S.K., Chung M.H. Ethyl pyruvate has an anti-inflammatory effect by inhibiting ROS-dependent STAT signaling in activated microglia. Free Radical Biology & Medicine 2008, 45:950-963.
28. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2002, 22:2478-2486.
29. Leviton A., Gilles F. Ventriculomegaly, delayed myelination, white matter hypoplasia, and periventricular leukomalacia: how are they related?. Pediatric Neurology 1996, 15:127-136.
30. Li J., Ramenaden E.R., Peng J., Koito H., Volpe J.J., Rosenberg P.A. Tumor necrosis factor alpha mediates lipopolysaccharide-induced microglial toxicity to developing oligodendrocytes when astrocytes are present. The Journal of Neuroscience: The Official Journal of the Society for Neuroscience 2008, 28:5321-5330.
31. Liang X., Chavez A.R., Schapiro N.E., Loughran P., Thorne S.H., Amoscato A.A., Zeh H.J., Beer-Stolz D., Lotze M.T., de Vera M.E. Ethyl pyruvate administration inhibits hepatic tumor growth. Journal of Leukocyte Biology 2009, 86:599-607.
32. Nitsos I., Rees S.M., Duncan J., Kramer B.W., Harding R., Newnham J.P., Moss T.J. Chronic exposure to intra-amniotic lipopolysaccharide affects the ovine fetal brain. Journal of the Society for Gynecologic Investigation 2006, 13:239-247.
33. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. Journal of Immunology 2004, 173:3916-3924.
34. Pang Y., Cai Z., Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Research. Developmental Brain Research 2003, 140:205-214.
35. Pang Y., Campbell L., Zheng B., Fan L., Cai Z., Rhodes P. Lipopolysaccharide-activated microglia induce death of oligodendrocyte progenitor cells and impede their development. Neuroscience 2010, 166:464-475.
36. Rousset C.I., Chalon S., Cantagrel S., Bodard S., Andres C., Gressens P., Saliba E. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatric Research 2006, 59:428-433.
37. Sappington P.L., Fink M.E., Yang R., Delude R.L., Fink M.P. Ethyl pyruvate provides durable protection against inflammation-induced intestinal epithelial barrier dysfunction. Shock 2003, 20:521-528.
38. Sarnat H.B. Ependymal reactions to injury. A review. Journal of Neuropathology and Experimental Neurology 1995, 54:1-15.
39. Segovia K.N., McClure M., Moravec M., Luo N.L., Wan Y., Gong X., Riddle A., Craig A., Struve J., Sherman L.S., Back S.A. Arrested oligodendrocyte lineage maturation in chronic perinatal white matter injury. Annals of Neurology 2008, 63:520-530.
40. Shen H., Hu X., Liu C., Wang S., Zhang W., Gao H., Stetler R.A., Gao Y., Chen J. Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms. Neurobiology of Disease 2010, 37:711-722.
41. Shen Y., Yu H.M., Yuan T.M., Gu W.Z., Wu Y.D. Intrauterine infection induced oligodendrocyte injury and inducible nitric oxide synthase expression in the developing rat brain. Journal of Perinatal Medicine 2007, 35:203-209.
42. Song M., Kellum J.A., Kaldas H., Fink M.P. Evidence that glutathione depletion is a mechanism responsible for the anti-inflammatory effects of ethyl pyruvate in cultured lipopolysaccharide-stimulated RAW 264.7 cells. The Journal of Pharmacology and Experimental Therapeutics 2004, 308:307-316.
43. Su X., Wang H., Zhao J., Pan H., Mao L. Beneficial effects of ethyl pyruvate through inhibiting high-mobility group box 1 expression and TLR4/NF-kappaB pathway after traumatic brain injury in the rat. Mediators of Inflammation 2011, 2011. 807142.
44. Tsung A., Kaizu T., Nakao A., Shao L., Bucher B., Fink M.P., Murase N., Geller D.A. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation 2005, 79:196-204.
45. Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C.J., Fink M.P., Tracey K.J. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:12351-12356.
46. van Zoelen M.A., de Vos A.F., Larosa G.J., Draing C., von Aulock S., van der Poll T. Intrapulmonary delivery of ethyl pyruvate attenuates lipopolysaccharide- and lipoteichoic acid-induced lung inflammation in vivo. Shock 2007, 28:570-575.
47. Wang L.Z., Sun W.C., Zhu X.Z. Ethyl pyruvate protects PC12 cells from dopamine-induced apoptosis. European Journal of Pharmacology 2005, 508:57-68.
48. Wang Q., Ding Q., Zhou Y., Gou X., Hou L., Chen S., Zhu Z., Xiong L. Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits. Anesthesiology 2009, 110:1279-1286.
49. Wang X., Rousset C.I., Hagberg H., Mallard C. Lipopolysaccharide-induced inflammation and perinatal brain injury. Seminars in Fetal & Neonatal Medicine 2006, 11:343-353.
50. Yang Z.Y., Ling Y., Yin T., Tao J., Xiong J.X., Wu H.S., Wang C.Y. Delayed ethyl pyruvate therapy attenuates experimental severe acute pancreatitis via reduced serum high mobility group box 1 levels in rats. World Journal of Gastroenterology: WJG 2008, 14:4546-4550.
51. Zhang Y., Li M., Meng M., Qin C. Effect of ethyl pyruvate on physical and immunological barriers of the small intestine in a rat model of sepsis. The Journal of Trauma 2009, 66:1355-1364.